Leadership

Board of Directors

Our Board of Directors is responsible for PolyPeptide’s overall direction and oversight of management, and holds the ultimate decision-making authority, with the exception of matters reserved for shareholders.

Peter Wilden

Chairman of the Board of Directors of PolyPeptide Group

Patrick Aebischer

Vice Chairman, Lead Independent Director of PolyPeptide Group

Beat In-Albon

Independent Member of the Board of Directors of PolyPeptide Group

Jane Salik

Member of the Board of Directors of PolyPeptide Group

Erik Schropp

Member of the Board of Directors of PolyPeptide Group

Philippe A. Weber

Independent Member of the Board of Directors of PolyPeptide Group

Executive Committee

The Board of Directors has delegated the responsibility and authority necessary or appropriate to carry out the day-to-day and
operational activities of PolyPeptide to the Executive Committee under the leadership of the CEO.

Peter Wilden Executive Chairman

Neil Thompson

Director Global Sales and Marketing and Member of the Executive Committee of PolyPeptide Group

Christina Del Vecchio

General Counsel and Member of the Executive Committee of PolyPeptide Group

Jan Fuhr Miller

Chief Financial Officer and Member of the Executive Committee of PolyPeptide Group

Jens Fricke

Director Global Operations and Member of the Executive Committee of PolyPeptide Group

PolyPeptide Management Committee

The Executive Committee is further supported by additional members of senior management with deep industry experience who, together with members of the Executive Committee, form the PolyPeptide Management Committee.

Jon Holbech Rasmussen

Director Global Development, IP and Regulatory

Monika Casanova_PMC

Monika Casanova

Chief Human Resources Officer

Olivier Ludemann-Hombourger

Director Global Innovation and Technology

Michael Stäheli

Head Investor Relations and Corporate Communications

Landon Piluso

Director Global Quality